IRIS
SACCANI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.216
EU - Europa 1.189
AS - Asia 660
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 3.085
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.195
CN - Cina 449
FI - Finlandia 330
SE - Svezia 278
IE - Irlanda 236
SG - Singapore 145
IT - Italia 107
DE - Germania 74
UA - Ucraina 71
TR - Turchia 47
AT - Austria 29
CA - Canada 21
GB - Regno Unito 16
CI - Costa d'Avorio 15
IN - India 15
FR - Francia 14
BE - Belgio 13
CZ - Repubblica Ceca 11
EU - Europa 5
IR - Iran 2
LT - Lituania 2
NL - Olanda 2
RU - Federazione Russa 2
CH - Svizzera 1
HU - Ungheria 1
JP - Giappone 1
MD - Moldavia 1
RO - Romania 1
VN - Vietnam 1
Totale 3.085
Salva come PNG Salva come JPEG
Città #
Chandler 277
Dublin 236
Singapore 120
Beijing 102
Jacksonville 99
Dearborn 96
Parma 81
Boardman 68
Nanjing 65
Shanghai 62
Ashburn 54
New York 52
Ann Arbor 48
Izmir 44
Princeton 39
Santa Clara 38
Vienna 29
Wilmington 24
Nanchang 23
San Mateo 23
Kunming 20
Hebei 19
Helsinki 19
Jinan 17
Bremen 16
Abidjan 15
Des Moines 15
Seattle 14
Brussels 13
Hefei 13
Guangzhou 12
Toronto 12
Pune 11
Shenyang 11
Brno 9
Changsha 9
Tianjin 9
Zhengzhou 9
Jiaxing 8
Norwalk 8
Hangzhou 7
London 5
Marseille 5
Munich 5
Ottawa 5
Cagliari 4
Chengdu 4
Fremont 4
Woodbridge 4
Augusta 3
Chongqing 3
Dallas 3
Fuzhou 3
Genoa 3
Grafing 3
Houston 3
Kocaeli 3
Manchester 3
Mantova 3
Rockville 3
Taizhou 3
Wenzhou 3
Düsseldorf 2
Frankfurt am Main 2
Gainesville 2
Haikou 2
Lanzhou 2
Mestre 2
Montreal 2
Montréal 2
Olomouc 2
Redmond 2
Redwood City 2
Reggio Nell'emilia 2
Xian 2
Alchevs'k 1
Bangalore 1
Baotou 1
Bologna 1
Borås 1
Budapest 1
Cardiff 1
Castel Goffredo 1
Chicago 1
Chisinau 1
Focsani 1
Goose Creek 1
Handan 1
Hanoi 1
Huizen 1
Jamaica Plain 1
Langfang 1
Leawood 1
Los Angeles 1
Modena 1
Montegaldella 1
New Delhi 1
Ningbo 1
Old Bridge 1
Philadelphia 1
Totale 1.972
Salva come PNG Salva come JPEG
Nome #
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 109
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 105
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 102
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 101
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 101
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung 99
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 95
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 95
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification 94
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 93
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 92
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 89
Erlotinib enhances antibody-dependent cellular cytotoxicity of wil-type erlotinib-sensitive NSCLC cell lines 88
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 88
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 87
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 86
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 85
Analgesic activity of new hybrid muscarinic agonists in mice 84
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 84
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 82
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 81
Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations 80
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 78
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 78
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 77
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 74
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 74
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 73
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 73
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 72
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 67
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 67
Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines 63
Pharmacological modulation of 5HT1A receptors in mice mesenteric ischemia/reperfusion injury: protective effect of Buspirone and WAY100135 61
Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice. 56
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 53
T-DM1: a new therapeutic approach in HER-2 overexpressing NSCLC cell lines 51
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 46
Investigation into the μ opioid receptor role in an experimental model of mesenteric ischemia/reperfusion 45
Totale 3.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020310 0 0 0 0 34 65 68 9 39 48 18 29
2020/2021153 1 19 7 1 20 2 20 0 36 14 33 0
2021/2022174 2 0 0 25 6 3 23 21 8 10 9 67
2022/2023984 119 132 62 85 81 113 24 38 271 2 46 11
2023/2024337 15 18 4 12 24 92 32 40 18 6 25 51
2024/2025277 26 45 52 64 90 0 0 0 0 0 0 0
Totale 3.128